Pulse Asia: 63% of Filipinos ‘distrust’ China-made vaccine, 44% ‘trust’ US jab

Published March 26, 2021, 6:23 PM

by Ellalyn De Vera-Ruiz

Pulse Asia’s survey results released on Friday, March 26 showed that 63 percent of Filipinos expressed “distrust” in China-made vaccines against the coronavirus disease (COVID-19).

The survey, which was conducted from Feb. 22 to March 3, 2021 with 2,400 respondents, also found 45 percent of Filipinos that expressed distrust in the vaccine developed by India.

Thirty-five percent distrust vaccines made by the United Kingdom and Russia, while 22 percent distrust the United States-developed vaccines.

Meanwhile, Pulse Asia found that a “big plurality” of Filipino adults (44 percent) trust COVID-19 vaccines developed in the United States.

Twenty-five percent trust the vaccine made by Russia, followed by the United Kingdom (22 percent), India (11 percent), and China (10 percent).

“Indecision is the plurality sentiment regarding the trustworthiness of those vaccines developed in the United Kingdom (43 percent) and Russia (40 percent),” Pulse Asia said.

The survey showed that almost every Filipino adult knew about the vaccines against COVID-19 developed in China (100 percent), the United States (99 percent), Russia (97 percent), the United Kingdom (96 percent), and India (93 percent).

During the same survey period, Pulse Asia found that the vaccine developed by US company Pfizer was the most preferred by those willing to be vaccinated against COVID-19.

Among Filipino adults inclined to get COVID-19 vaccine, 52 percent chose the vaccine developed by Pfizer -“a view echoed by small pluralities to huge majorities across geographic areas and socio-economic groupings (38 percent to 73 percent and 48 percent to 73 percent, respectively).”

Meanwhile, 22 percent favor the vaccine by Chinese company Sinovac Biotech.

Other COVID-19 vaccines preferred by at least 1 percent of those willing to get vaccinated against the disease were those manufactured by UK’s AstraZeneca (6 percent), Russian firm Gamaleya Research Institute (3 percent), US company Johnson & Johnson (1 percent), Chinese firm Sinopharm (1 percent), and US company Moderna (1 percent).

The rest of Filipinos inclined to be vaccinated were either undecided about which COVID-19 vaccine to get (6 percent) or were willing to be injected with whichever vaccine is available (9 percent).